Neurostimulation for Cognitive Rehabilitation in Stroke (NeuroCog)
Neurostimulation for Cognitive Enhancement After Stroke (NeuroCog)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
PB
-
João Pessoa, PB, Brazil
- Recruiting
- Suellen Andrade
-
Contact:
- Suellen Andrade
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ischaemic chronic stroke
- Mild/Moderate Cognitive impairment
- Informed consent
Exclusion Criteria:
- National Institute of Health Stroke Scale (NIHSS) ≥ 16 points
- Severe cognitive comorbidities (dementia, depression)
- transcranial direct current stimulation criteria: use of modulators of the Central Nervous System drugs; patients with implanted metallic or electronic devices; pacemaker; seizures; pregnancy;any other condition that might limit or interfere in the sensorimotor system
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: dlPFC
Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in dorsolateral prefrontal cortex
|
Other Names:
|
|
Experimental: CON
Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in cingulo-opercular network
|
Other Names:
|
|
Active Comparator: M1
Participants in the chronic post-stroke stage will receive active transcranial direct current stimulation in motor primary cortex
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Executive Function measured by Dysexecutive Questionnaire (DEX)
Time Frame: Change for executive functions at 4 weeks
|
Change for executive functions at 4 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Verbal Fluency (Semantic Fluency Test)
Time Frame: [ Time Frame: Baseline, Week 2 and Week 4 ]
|
[ Time Frame: Baseline, Week 2 and Week 4 ]
|
|
Response inhibition (Go-no-go Test)
Time Frame: [ Time Frame: Baseline, Week 2 and Week 4 ]
|
[ Time Frame: Baseline, Week 2 and Week 4 ]
|
|
Executive function (Wechsler Intelligence Scale for Adults)
Time Frame: [ Time Frame: Baseline, Week 2 and Week 4 ]
|
[ Time Frame: Baseline, Week 2 and Week 4 ]
|
|
Memory (Rey Auditory Verbal Learning)
Time Frame: [ Time Frame: Baseline, Week 2 and Week 4 ]
|
[ Time Frame: Baseline, Week 2 and Week 4 ]
|
|
Processing Speed (Letter Comparison and Pattern Comparison Tasks)
Time Frame: [ Time Frame: Baseline, Week 2 and Week 4 ]
|
[ Time Frame: Baseline, Week 2 and Week 4 ]
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Suellen Andrade, PhD, Federal University of Paraíba
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- NeuroCog001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.